KIF2C通过PLK1上调促进口腔状细胞癌的进展:对生物标志物发展和治疗向的影响
Chenfei Wang1, Yuyuan Su1, Jinlong Shi2
1Department of Oral and Maxillofacial Surgery, Affiliated Hospital of Nantong University, Nantong, 226001, China.
Journal of molecular histology
|April 28, 2025
概括
素家族成员2C (KIF2C) 和波罗样酶1 (PLK1) 在口腔状细胞癌 (OSCC) 中被上调. 向KIF2C通过PLK1信号抑制OSCC的进展,表明它们作为治疗点的潜力.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 癌症研究 癌症研究
背景情况:
- 口腔状细胞癌 (OSCC) 由于其具有攻击性,晚期检测和高转移潜力而构成重大临床挑战.
- 新的治疗目标对于改善OSCC管理结果至关重要.
研究的目的:
- 调查素家族成员2C (KIF2C) 和Polo样酶1 (PLK1) 在OSCC进展中的作用.
- 阐明OSCC中KIF2C和PLK1之间的功能相互作用.
主要方法:
- 免疫组织化学和西部斑分析以评估OSCC组织和细胞系中的KIF2C和PLK1表达.
- 通过siRNA介导的KIF2C在Cal27细胞中的淘汰,以评估其对增殖,迁移,入侵,EMT,亡和细胞周期的功能影响.
- 定量PCR (qPCR),CCK-8,EDU,Transwell,伤口愈合试验和流细胞测量以确认机械联系和功能结果.
主要成果:
- 在人类OSCC组织和细胞系中,KIF2C和PLK1显著上调.
- KIF2C的敲除抑制了OSCC细胞的增殖,迁移,入侵和上皮细胞-介质细胞过渡 (EMT),同时诱导了细胞亡和G0/G1细胞周期停止.
- KIF2C沉默导致PLK1表达减少,EMT标记物减少,矩阵金属蛋白酶 (MMP) 和血管生成因子减少,证实KIF2C-PLK1轴促进瘤生长.
结论:
- KIF2C作为OSCC进展的关键调节者,主要通过PLK1-介导的信号通路.
- KIF2C和PLK1代表了有希望的预后生物标志物和有效OSCC管理的潜在治疗目标.
相关概念视频
MAPK Signaling Cascades
4.9K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
4.9K
Inhibition of Cdk Activity
4.5K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.5K
Tumor Progression
6.1K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.1K
PI3K/mTOR/AKT Signaling Pathway
3.3K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.3K
Cancer-Critical Genes II: Tumor Suppressor Genes
7.2K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.2K
mTOR Signaling and Cancer Progression
3.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.6K


